Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q7919041> ?p ?o }
Showing triples 1 to 35 of
35
with 100 triples per page.
- Q7919041 subject Q8431759.
- Q7919041 subject Q8707914.
- Q7919041 abstract "Veliparib (ABT-888) is a potential anti-cancer drug acting as a PARP inhibitor. It kills cancer cells by blocking a protein called PARP, thereby preventing the repair of DNA or genetic damage in cancer cells and possibly making them more susceptible to anticancer treatments. Veliparib may make whole brain radiation treatment work more effectively against brain metastases from NSCLC.It inhibits both PARP1 and PARP2.".
- Q7919041 atcPrefix "none".
- Q7919041 drugbank "DB07232".
- Q7919041 fdaUniiCode "01O4K0631N".
- Q7919041 iupacName "2-((R)-2-Methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide".
- Q7919041 pubchem "11960529".
- Q7919041 thumbnail Veliparib_skeletal.svg?width=300.
- Q7919041 wikiPageExternalLink new-drug-study-method-show-breast-cancer-promise.
- Q7919041 wikiPageWikiLink Q128581.
- Q7919041 wikiPageWikiLink Q16242548.
- Q7919041 wikiPageWikiLink Q17710375.
- Q7919041 wikiPageWikiLink Q18034972.
- Q7919041 wikiPageWikiLink Q180614.
- Q7919041 wikiPageWikiLink Q18936.
- Q7919041 wikiPageWikiLink Q30612.
- Q7919041 wikiPageWikiLink Q419953.
- Q7919041 wikiPageWikiLink Q659446.
- Q7919041 wikiPageWikiLink Q7118227.
- Q7919041 wikiPageWikiLink Q8431759.
- Q7919041 wikiPageWikiLink Q8707914.
- Q7919041 atcPrefix "none".
- Q7919041 drugbank "DB07232".
- Q7919041 iupacName "2".
- Q7919041 pubchem "11960529".
- Q7919041 unii "1".
- Q7919041 type ChemicalSubstance.
- Q7919041 type Drug.
- Q7919041 type ChemicalObject.
- Q7919041 type Thing.
- Q7919041 type Q8386.
- Q7919041 comment "Veliparib (ABT-888) is a potential anti-cancer drug acting as a PARP inhibitor. It kills cancer cells by blocking a protein called PARP, thereby preventing the repair of DNA or genetic damage in cancer cells and possibly making them more susceptible to anticancer treatments. Veliparib may make whole brain radiation treatment work more effectively against brain metastases from NSCLC.It inhibits both PARP1 and PARP2.".
- Q7919041 label "Veliparib".
- Q7919041 depiction Veliparib_skeletal.svg.